newsfilter
← Latest News
GlobeNewswire·

Cyclerion Therapeutics to Participate in Two Upcoming Investor Conferences

CAMBRIDGE, Mass., Sept. 08, 2021 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (NASDAQ:CYCN), a clinical-stage biopharmaceutical company on a mission to develop treatments that restore cognitive function, today announced that Company management will